63 results on '"Topp M"'
Search Results
2. 3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant
3. Glofitamab plus immunochemotherapy demonstrates durable efficacy with manageable safety in relapsed/refractory non‐Hodgkin lymphoma (R/R NHL): update of a Phase Ib study
4. CXCR4-gerichtete PET/CT in 100 Patient:innen mit Marginalzonenlymphom -Diagnostische Performance, Vorhersagepotenzial und Eignung für CXCR4-Endoradiotherapie
5. Einfluss einer erhöhten Manifestations-Last auf die Ga-68-PentixaFor Biodistribution bei Patient:innen mit Marginalzonenlymphom - Potentielle therapeutische Implikationen
6. P356: SUBGROUP ANALYSES OF KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL) IN ZUMA-3
7. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
8. CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS
9. OUTCOME DETERMINANTS OF COMMERCIAL CAR‐T CELL THERAPY FOR LARGE B‐CELL LYMPHOMA: RESULTS OF THE GLA/DRST REAL WORLD ANALYSIS
10. Application of T Cell lmmunotherapy for Human Viral and Malignant Diseases
11. Fast relaxation processes in jet-cooled van der Waals clusters involving large aromatic molecules
12. PS1240 EVEROLIMUS WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
13. S825 EVALUATION OF AMG 420, AN ANTI‐BCMA BISPECIFIC T‐CELL ENGAGER (BITE®) IMMUNOTHERAPY, IN R/R MULTIPLE MYELOMA (MM) PATIENTS: UPDATED RESULTS OF A FIRST‐IN‐HUMAN (FIH) PHASE 1 DOSE ESCALATION STUDY
14. PB1780 TREATMENT OF R/R BURKITT LYMPHOMA WITH BLINATUMOMAB IS FEASIBLE AND INDUCED A LONG LASTING COMPLETE REMISSION
15. Neue Entwicklungen in der Therapie des fortgeschrittenen klassischen Hodgkin-Lymphoms
16. Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
17. Preliminary results of novel safety interventions in adult patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) in the ZUMA-3 Trial
18. Interim results from a phase 1 first-in-human study of flotetuzumab, a CD123 x CD3 bispecific DART molecule, in AML/MDS
19. PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION IN UNTREATED DLBCL: RESULTS FROM THE PHASE III GOYA STUDY
20. Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL
21. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
22. The Excited-State Proton Transfer Reactions of Flavonols in Alcoholic Solvents
23. Stabilization of Solid-State Lasers for Picosecond Transient Spectroscopy
24. Picosecond Measurements of Radiative and Radiationless Relaxation Processes in Aromatic Molecules
25. Fluorescence Spectroscopy of Ultrashort-Lived States of Aromatic Compounds
26. New Developments in Picosecond Time-Resolved Fluorescence Spectroscopy: Vibrational Relaxation Phenomena
27. Measurement of Singlet Lifetimes by Upper State Fluorescence Excitation
28. Fluorescence Spectroscopy of Subpicosecond States in Liquids
29. GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6
30. Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia
31. NLO Monte Carlo predictions for heavy-quark production at the LHC: pp collisions in ALICE
32. OP0024 Use of novel patient-derived xenografts and molecular subtyping to improve precision medicine in high-grade serous ovarian cancer
33. Recruit-Tandab AFM13 - Overcoming Limitations of Monoclonal Antibodies in Hodgkin Lymphoma
34. ChemInform Abstract: Ground-State and Excited-State Rotational Constants of p- Cyclohexylaniline.
35. Auto-SCT in severe paraproteinemic neuropathy
36. Sacco and Vanzetti: The Men, the Murders, and the Judgment of Mankind. By Bruce Watson. (New York: Viking, 2007. 433 pp. $25.95, ISBN 978-0-670-06353-6.)
37. 52-jähriger Patient mit schwerer Herzinsuffizienz bei multiplem Myelom
38. Cellulose als Verarbeitungshilfe in Polymerkompositen
39. Correlations of Structure and Rates of Energy Transfer for Through-Bond Energy-Transfer Cassettes
40. Is complement activation combined with antibody removal the mystery of successful immunoadsorption in multiple sclerosis?
41. Quasi-Living Polymerization of N-Isopropylacrylamide onto Poly(ethylene glycol)
42. 030 A correlation between a change of neonatal very low birth weight-treatment and a reduction of cerebral palsy birth prevalence
43. Thermosensitive Micelle-Forming Block Copolymers of Poly(ethylene glycol) and Poly(N-isopropylacrylamide)
44. Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34(+) hematopoietic cells
45. Supertough poly(lactide)s
46. Electronic coupling and conformational barrier crossing of 9,9′-bifluorenyl studied in a supersonic jet
47. ChemInform Abstract: Hot‐Band Spectroscopy of Ground‐State Levels of Perylene Following Predissociation of van der Waals Complexes.
48. Pulsed Laser Spectroscopy
49. Preparation, ion transport, and spectroscopy of Eu(II) and Eu(III) beta″ alumina
50. ChemInform Abstract: Spectroscopy of a Picosecond Excited State: The S2(B1u) ←→ S0(A1g) Transition of Coronene.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.